BIOCARD Study Publication List

2024

  • Callow D, Spira A, Zipunnikov V, Lu H, Wanigatunga S, Rabinowitz J, Albert M, Bakker A, Soldan A. Sleep and physical activity measures are associated with resting-state network segregation in non-demented older adults. Neuroimage Clinical, 2024; 43: 103621. PMCID: PMC11179421
  • Soldan A, Wang J, Pettigrew C, Davatzikos C, Erus G, Hohman T, Dumitrescu L, Bilgel M, Resnick S, Rivera-Rivera L, Langhough R, Johnson S, Benzinger T, Morris J, Laws S, Fripp J, Masters C, Albert M. Alzheimer disease genetic risk and changes in brain atrophy and WMH in cognitively unimpaired adults. Brain Communications, 2024; 6: fcae276. PMCID: PMC11369827
  • Callow D, Zippunikov V, Spira A, Wanigatunga S, Pettigrew C, Albert M, Soldan A. Activity estimates of sleep quality moderates the relationship between physical activity and cognition in older adults. Mental Health and Physical Activity, 2024; 10573. PMCID: PMC10803079
  • Skampardoni I, Nasrallah I, Abdulkadir A, Wen J, Melhem R, Mamourian E, Erus G, Doshi J, Singh A, Yang Z, Cui Y, Hwang G, Ren Z, Pomponio R, Srinivasan D, Govindarajan S, Parmpi P, Wittfeld K, Grabe H, Bülow R, Frenzel S, Tosun D, Bilgel M, An Y, Marcus D, LaMontagne P. Heckbert S, Austin T, Launer L, Sotiras A, Espeland M, Masters C, Maruff P, Fripp J, Johnson S, Morris J, Albert M, Bryan N, Yaffe K, Völzke H, Ferrucci L, Benzinger T, Ezzati A, Shinohara R, Fan Y, Resnick S, Habes M, Wolk D, Shou H, Nikita K, Davatzikos C. Genetic and clinical correlates of AI-based aging patterns in cognitively unimpaired individuals. JAMA Psychiatry, 2024; 81: 456-467. PMCID: PMC10867776
  • Stouffer K, Grande X, Duzel E, Johansson M, Creese B, Witter M, Miller M, Wisse L, Berron D. Amidst an amygdala renaissance in Alzheimer’s disease. Brain, 2024; 147: 816-829. PMCID: PMC10907090.
  • Yang Z, Wen J, Abdulkadir A, Cui Y, Erus G, Mamourian E, Melhem R, Srinivasan D, Govindarajan ST, Chen J, Habes M, Masters CL, Maruff P, Fripp J, Ferrucci L, Albert MS, Johnson SC, Morris JC, LaMontagne P, Marcus DS, Benzinger TLS, Wolk DA, Shen L, Bao J, Resnick SM, Shou H, Nasrallah IM, Davatzikos C. Gene-SGAN: discovering disease subtypes with imaging and genetic signatures via multi-view weakly-supervised deep clustering. Nature Communications. 2024;15: 354. PMCID: PMC10774282
  • Wen J, Yang Z, Nasrallah IM, Cui Y, Erus G, Srinivasan D, Abdulkadir A, Mamourian E, Hwang G, Singh A, Bergman M, Bao J, Varol E, Zhou Z, Boquet-Pujadas A, Chen J, Toga AW, Saykin AJ, Hohman TJ, Thompson PM, Villeneuve S, Gollub R, Sotiras A, Wittfeld K, Grabe HJ, Tosun D, Bilgel M, An Y, Marcus DS, LaMontagne P, Benzinger TL, Heckbert SR, Austin TR, Launer LJ, Espeland M, Masters CL, Maruff P, Fripp J, Johnson SC, Morris JC, Albert MS, Bryan RN, Resnick SM, Ferrucci L, Fan Y, Habes M, Wolk D, Shen L, Shou H, Davatzikos C. Genetic and clinical correlates of two neuroanatomical AI dimensions in the Alzheimer’s disease continuum. Transl Psychiatry. 2024; 14: 420. PMCID: PMC11455841.
  • Yang Z, Wen J, Erus G, Govindarajan ST, Melhem R, Mamourian E, Cui Y, Srinivasan D, Abdulkadir A, Parmpi P, Wittfeld K, Grabe HJ, Bülow R, Frenzel S, Tosun D, Bilgel M, An Y, Yi D, Marcus DS, LaMontagne P, Benzinger TLS, Heckbert SR, Austin TR, Waldstein SR, Evans MK, Zonderman AB, Launer LJ, Sotiras A, Espeland MA, Masters CL, Maruff P, Fripp J, Toga AW, O’Bryant S, Chakravarty MM, Villeneuve S, Johnson SC, Morris JC, Albert MS, Yaffe K, Völzke H, Ferrucci L, Nick Bryan R, Shinohara RT, Fan Y, Habes M, Lalousis PA, Koutsouleris N, Wolk DA, Resnick SM, Shou H, Nasrallah IM, Davatzikos C. Brain aging patterns in a large, diverse cohort of 49,482 individuals. Nat Med. 2024; 10: 3015-3026. PMCID: PMC11483219
  • Peterson A, Sathe , Zaras D, Yang Y, Durant A, Deters K, Shashikumar N, Pechman K, Kim M, Gao C, Khairi N, Li Z, Yao T, Huo Y, Dumitrescu L, Gifford K, Wilson J, Cambronero F, Risacher S, Beason-Held L An Y, Arfanakis K, Erus G, Davatzikos C, Tosum D, Toga A, Thompson P, Mormino E, Zhang P, Schilling K, Albert M, Kukull W, Biber S, Landman B, Johnson S, Schneider J, Barnes L, Bennett D, Jefferson A, Resnick S, Saykin A, Hohman T, Archer D Sex, racial, and APOE-ε4 allele differences in longitudinal white matter microstructure in multiple cohorts of aging and Alzheimer’s disease. bioRxiv, 2024. PMCID: PMC1195046
  • Uchida Y, Nishimaki K, Soldan A, Moghekar A, Albert M, Oishi, K. Acceleration of brain atrophy and progression from normal cognition to mild cognitive impairment, JAMA Network Open, 2024, 7: e2441504. PMCID: PMC11525609.
  • Soldan A, Pettigrew C, Wang J, Albert M, Blennow K, Bittner T, Moghekar A. Blood-based biomarkers and risk of onset of mild cognitive impairment over the short and long-term, Neurology, in press
  • Archer D, Peterson A, Sathe A, Zaras D, Yang Y, Durant A, Deters K, Shashikumar N, Pechman K, Kim M, Gao C, Khairi N, Li Z, Yao T, Huo Y, Dumitrescu L, Gifford K, Wilson J, Cambronero F, Risacher S, Beason-Held L, An Y, Arfanakis K, Erus G, Davatzikos C, Tosun D, Toga A, Thompson P, Mormino E, Habes M, Wang D, Zhang P, Schilling K, Albert M, Kukull W, Biber S, Landman B, Johnson S, Schneider J, Barnes L, Bennett D, Jefferson A, Resnick S, Saykin A, Hohman T. Sex and APOE-ε4 allele differences in longitudinal white matter microstructure in multiple cohorts of aging and Alzheimer’s disease. Alzheimer’s & Dementia, in press.
  • Govindarajan S, Mamourian E, Erus G, Abdulkadir A, Melhem R, Tosun-Turgut D, Bilgel M, An Y, Sotiras A, Marcus D, LaMontagne P, Benzinger T, Espeland M, Masters C, Maruff P, Fripp J, Johnson S, Morris J, Albert M, Bryan N, Resnick S, Habes M, Haochang S, Wolk D, Nasrallah I, Davatzikos C. Machine learning reveals distinct neuroanatomical signatures of cardiovascular and metabolic diseases in cognitively unimpaired individuals. Nature Communications, in press.
  • Callow D, Spira A, Zipunnikov V, Pettigrew C, Faria A, Wanigatunga S, Rabinowitz J, Albert M, Bakker A, Soldan A. Independent associations of sleep and physical activity with cognition are mediated by hippocampal microstructure in middle age and older adults. Neurobiology of Aging, in press

2023

  • Soldan A, Oh S, Ryu T, Pettigrew C, Zhu Y, Moghekar A, Xiao M-F, Pontone G, Albert M, Na C-H, Worley P. NPTX2 in cerebrospinal fluid predicts progression to mild cognitive impairment, Annals of Neurology, 2023; 94:620-631. PMCID: PMC10543570
  • Kamalian A, Ho S, Patel M, Lewis A, Bakker A, Albert M, O’Brien R, Moghekar A, Lutz M. Exploratory assessment of proteomic network changes in cerebrospinal fluid of mild cognitive impairment patients: a pilot study. Biomolecules, 2023; 13:1094. PMCID: PMC10377001
  • Sun Y, Moghekar A, Soldan A, Pettigrew C, Greenberg B, Albert M, Wang M-C. Cerebrospinal fluid Alzheimer’s disease biomarkers patterns of change prior to the onset of mild cognitive impairment. Journal of Alzheimer’s Disease, 2023; 96:287-300. PMCID: PMC10793182
  • Rani N, Alm K, Corona-Long C, Speck C, Soldan A, Pettigrew C, Zhu Y, Albert M, Bakker A. Tau accumulation in Brodmann areas 35 and 36 is associated with individual differences in cognition in non-demented older adults. Frontiers in Aging Neuroscience, 2023; 15: 1272946. PMCID: PMC10757623
  • Yang Z, Wen J, Erus G, Govindarajan ST, Melhem R, Mamourian E, Cui Y, Srinivasan D, Abdulkadir A, Parmpi P, Wittfeld K, Grabe HJ, Bülow R, Frenzel S, Tosun D, Bilgel M, An Y, Yi D, Marcus DS, LaMontagne P, Benzinger TLS, Heckbert SR, Austin TR, Waldstein SR, Evans MK, Zonderman AB, Launer LJ, Sotiras A, Espeland MA, Masters CL, Maruff P, Fripp J, Toga A, O’Bryant S, Chakravarty MM, Villeneuve S, Johnson SC, Morris JC, Albert MS, Yaffe K, Völzke H, Ferrucci L, Bryan NR, Shinohara RT, Fan Y, Habes M, Lalousis PA, Koutsouleris N, Wolk DA, Resnick SM, Shou H, Nasrallah IM, Davatzikos C. Five dominant dimensions of brain aging are identified via associations with clinical, lifestyle and genetic measures. medRxiv, 2023; 12.29.23300642. PMCID: PMC10793525
  • Wen J, Nasrallah IM, Abdulkadir A, Satterthwaite TD, Yang Z, Erus G, Robert-Fitzgerald T, Singh A, Sotiras A, Boquet-Pujadas A, Mamourian E, Doshi J, Cui Y, Srinivasan D, Skampardoni I, Chen J, Hwang G, Bergman M, Bao J, Veturi Y, Zhou Z, Yang S, Dazzan P, Kahn RS, Schnack HG, Zanetti MV, Meisenzahl E, Busatto GF, Crespo-Facorro B, Pantelis C, Wood SJ, Zhuo C, Shinohara RT, Gur RC, Gur RE, Koutsouleris N, Wolf DH, Saykin AJ, Ritchie MD, Shen L, Thompson PM, Colliot O, Wittfeld K, Grabe HJ, Tosun D, Bilgel M, An Y, Marcus DS, LaMontagne P, Heckbert SR, Austin TR, Launer LJ, Espeland M, Masters CL, Maruff P, Fripp J, Johnson SC, Morris JC, Albert MS, Bryan RN, Resnick SM, Fan Y, Habes M, Wolk D, Shou H, Davatzikos C. Genomic loci influence structural patterns in the human brain. Proc Natl Acad Sci U S A. 2023 Dec 26;120(52):e2300842120. PMCID: PMC 10756284
  • Stouffer K, Chen C, Kulason S, Xu E, Witter M, Ceritoglu C, Albert M, Mori S, Troncoso J, Tward D, Miller M. Early amygdala and ERC atrophy linked to 3D reconstruction of rostral tau tangle neurofibrillary pathology in Alzheimer’s disease. Neuroimage Clinical, 2023; 38: 103374. PMCID: PM10034129
  • Pettigrew C, Nazarovs J, Soldan A, Singh V, Wang J, Hohman T, Dumitrescu L, Libby J, Kunkle B, Gross A, Johnson S, Lu Q, Engelman C, Masters C, Maruff P, Laws S, Morris J, Hassenstab J, Cruchaga C, Resnick S, Kitner-Triolo M, An Y, Albert M. Alzheimer’s disease genetic risk and cognitive reserve in relationship to cognitive trajectories among cognitively normal individuals. Alzheimer’s Research and Therapy, 2023;15:66. PMCID: PMC10045505
  • Newton P, Tchounguen J, Pettigrew C, Lim C, Lin Z, Lu H, Moghekar A, Albert M, Soldan A. Regional white matter hyperintensities and Alzheimer’s disease biomarkers among older adults with normal cognition and mild cognitive impairment. Journal of Alzheimer’s Disease, 2023; 92: 323-339. PMCID: PMC10041440
  • Lin Z, Lim C, Jiang D, Soldan A, Pettigrew C, Oishi K, Liu P, Albert M, Lu H. Longitudinal changes in brain oxygen extraction fraction (OEF) in older adults: relationship to vascular and Alzheimer’s pathology. Alzheimer’s & Dementia, 2023; 19:569-577. PMCID: PMC10838398

2022

  • Alm K, Soldan A, Pettigrew C, Faria A, Hou X, Lu H, Moghekar A, Mori S, Albert M, Bakker A. Structural and functional brain connectivity uniquely contribute to episodic memory performance in older adults. Frontiers in Aging Neuroscience, 2022; 14: 951076. PMCID: PMC9315224.
  • Pettigrew C, Soldan A, Wang J, Wang M-C, Greenberg B, Albert M, Moghekar A. Longitudinal CSF Alzheimer’s biomarker changes from middle age to late adulthood. Alzheimer’s & Dementia: Diagnosis, Assessment and Disease Monitoring, 2022; 14: e12374. PMCID: PMC9673459
  • Hwang G, Abdulkadir A, Erus G, Habes M, Pomponio R, Shou H, Doshi J, Mamourian E, Rashid T, Bilgel M, Fan Y, Sotiras A, Srinivasan D, Morris J, Albert M, Bryan N, Resnick S, Nasrallah I, Davatzikos C, Wolk D. Disentangling Alzheimer’s disease neurodegeneration from typical brain aging using machine learning. Brain Communications, 2022; 4: fcac117. PMCID: PMC9123890
  • Wen J, Fu CHY, Tosun D, Veturi Y, Yang Z, Abdulkadir A, Mamourian E, Srinivasan D, Skampardoni I, Singh A, Nawani H, Bao J, Erus G, Shou H, Habes M, Doshi J, Varol E, Mackin RS, Sotiras A, Fan Y, Saykin AJ, Sheline YI, Shen L, Ritchie MD, Wolk DA, Albert M, Resnick SM, Davatzikos C. Characterizing heterogeneity in neuroimaging, clinical symptoms, and genetics among patients with late life depression. JAMA Psychiatry. 2022 May 1;79(5):464-474. PMCID: PMC8908227
  • Betthauser T, Bilgel M, Koscik R, Jedynak B, An Y, Kellett K, Moghekar A, Jonaitis E, Stone C, Engelman C, Asthana S, Christian B, Wong D, Albert M, Resnick S, Johnson S. Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts. Brain 2022; 145:4065-4079. PMCID: PMC9679170
  • Chan C, Pettigrew C, Soldan A, Zhu Y, Wang M-C, Albert M, Rosenberg P. Association between late life neuropsychiatric symptoms and cognitive decline in relation to white matter hyperintensities and amyloid burden, Journal of Alzheimer’s Disease, 2022; 86: 1415-1426. PMCID: PMC9969328.
  • Luo J, Agboola F, Grant E, Morris J, Masters C, Albert M, Johnson S, McDade E, Fagan A, Benzinger T, Hassenstab J, Bateman R, Perrin R, Wang G, Li Y, Gordon B, Cruchaga C, Day G, Levin J, Vöglein J, Ikeuchi T, Suzuki K, Allegri R, Xiong C. Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan, Brain, 2022, 145: 4459-4473. PMCID: PMC10200301
  • Greenberg BD, Pettigrew C, Soldan A, Wang J, Wang MC, Darrow J, Albert M, Moghekar A. CSF Alzheimer’s Disease biomarkers: Time-varying relationships with MCI symptom onset, and associations with age, sex and ApoE4. Neurology, 2022; 99: e1640-e1650. PMCID: PMC9559947
  • Bashyam V, Doshi J, Erus G, Srinivasan D, Abdulkadir A, Habes M, Fan Y, Launer L, Masters C, Maruff P, Zhuo C, Völzke H, Johnson S, Fripp J, Koutsouleris N, Satterthwaite T, Wolf D, Gur R, Gur R, Morris J, Albert M, Grabe H, Resnick S, Bryan RN, Wolk D, Shou H, Nasrallah I, Davatzikos C, Deep generative medical image harmonization for improving cross-site generalization in deep learning predictors. Magnetic Resonance Imaging, 2022; 5: 908-916. PMCID: PMC8844038.
  • Pettigrew C, Soldan A, Brichko R, Zhu Y, Wang M-C, Kutten K, Bilgel M, Mori S, Miller M, Albert M. Computerized paired associate learning performance and imaging biomarkers in older adults without dementia. Brain Imaging and Behavior, 2022; 16: 921-929. PMCID: PMC9012682.
  • Wen J, Fu C, Tosun D, Veturi Y, Yang Z, Abdulkadir A, Mamourian E, Srinivasan D, Bao J, Erus G, Shou H, Habes M, Doshi J, Varol E, Mackin S, Sotiras A, Fan Y, Saykin A, Sheline Y, Shen L, Ritchie M, Wolk D, Albert M, Resnick S, Davatzikos C. Characterizing heterogeneity in neuroimaging, cognition, clinical symptoms, and genetics among patients with later-life depression. JAMA Psychiatry, 2022; 79: 464-474. PMCID: PMC8908227
  • Brichko R, Soldan A, Zhu Y, Wang MC, Faria A, Albert M, Pettigrew C. Age-dependent association between cognitive reserve proxy and longitudinal white matter microstructure in older adults. Frontiers in Psychology, 2022; 13: 859826. PMCID: PMC8210464.
  • Seto M, Mahoney ER, Dumitrescu L, Ramanan VK, Engelman CD, Deming Y, Albert M, Johnson SC, Zetterberg H, Blennow K, Vemuri P, Jefferson AL, Hohman TJ. Exploring genetic contributors to neuroprotection from amyloid pathology. Brain Communications, 2022; 4: fcac066. PMCID: PMC9006043
  • Oishi K, Soldan A, Pettigrew C, Hsu J, Mori S, Albert M, Oishi K. Changes in pairwise functional connectivity associated with changes in cognitive performance in cognitively normal older individuals: A two-year observational study. Neuroscience Letters, 2022; 781:136618. PMCID: PMC9990522.
  • Han H, Lin Z, Soldan A, Pettigrew C, Betz JF, Oishi K, Li Y, Liu P, Albert M, Lu H. Longitudinal changes in global cerebral blood flow in cognitively normal older adults: A phase-contrast MRI study. Journal of Magnetic Resonance Imaging, 2022; 56: 1538-1545. PMCID: PMC9411265
  • Soldan A, Alfini A, Pettigrew C, Faria A, Hou X, Lim C, Lu H, Spira A, Zipunnikov V, Albert M. Actigraphy-estimated physical activity is associated with functional and structural brain connectivity among older adults, Neurobiology of Aging, 2022;116: 32-40. PMCID: PMC10167793
  • Zhu Y, Wang MC. Obtaining optimal cutoff values for tree classifiers using multiple biomarkers. Biometrics, 2022; 78: 128-140. PMCID: PMC8557826

2021

  • Soldan A, Pettigrew C, Zhu Y, Wang M-C, Bilgel M, Hou Z, Lu H, Miller M, Albert M. Association of lifestyle activities with functional brain connectivity and relationship to cognitive reserve among older adults. Cerebral Cortex, 2021; 31: 5637-5651. PMCID: PMC8568002
  • Alfini A, Albert M, Faria A, Soldan A, Pettigrew C, Wanigatunga S , Zipunnikov V, Spira A. Associations of actigraphic sleep and circadian rest/activity rhythms with cognition in the early phase of Alzheimer’s disease. Sleep Advances, 2021; 2: zpab007. PMCID: PMC8168567.
  • Chen L, Soldan A, Oishi K, Faria A, Zhu Y, Albert M, vanZijl P, Li X. Quantitative susceptibility mapping of brain iron and beta-amyloid in MRI and PET relating to cognitive performance in cognitively normal older adults. Radiology, 2021; 298: 353-362. PMCID: PMC7850239
  • Habes M, Pomponio R, Shou H, Doshi J, Mamourian L, Erus G, Nasrallah I, Launer L, Rashid T, Bilgel M, Fan Y, Toledo J, Yaffe K, Sotiras A, Srinivasan D, Espeland M, Masters C, Völzk H, Johnson S, Morris J, Albert M, Miller M, Bryan N, Grabe H, Resnick S, Wolk D, Davatzikos C. The Brain Chart of Aging: Machine learning analytics reveals links between brain aging, white matter disease, amyloid burden and cognition in the iStaging consortium of 10,215 harmonized MR scans. Alzheimer’s & Dementia, 2021; 17: 89-102. PMCID: PMC7923395
  • Yang Z, Nasrallah I, Shou H, Wen J, Doshi J, Habes M, Erus G, Abdulkadir A, Resnick S, Albert M, Maruff P, Fripp J, Morris J, Wolk D, Davatzikos C. A deep-learning framework identifies dimensional representations of Alzheimer’s Disease from brain structure, Nature Communication, 2021; 12: 7065. PMCID: PMC8642554.
  • Byeon S, Madugundu A, Jain A, Bhat F, Jung J, Renuse S, Darrow J, Bakker A, Albert M, Moghekar A, Pandey A. Cerebrospinal fluid lipidomics for biomarkers of Alzheimer’s disease. Molecular OMICS, 2021, 17: 454-463. PMCID: PMC8210464.
  • Darrow J, Calabro A, Gannon A, Orusakwe A, Esquivel R, Traynham CJ, Rao A, Gulyani A, Khingelova K, Bandeen-Roche K, Albert M, Moghekar A. Effect of patient specific pre-analytic variables on CSF Aβ 1-42 concentrations measured on an automated chemiluminescent platform, Journal of Applied Laboratory Medicine, 2021; 6: 397-408. PMCID PMC8482291
  • Sathe G, Albert M, Darrow J, Atsushi Saito, Troncoso J, Pandey A, Moghekar. Quantitative proteomic profiling of the frontal cortex in Alzheimer’s disease. Journal of Neurochemistry, 2021; 10:111. PMCID: PMC7775912.

2020

  • Alm K, Faria A, Moghekar A, Pettigrew C, Soldan A, Mori S, Albert M, Bakker A. Medial temporal lobe white matter pathway variability is associated with individual differences in episodic memory in cognitively normal older adults. Neurobiology of Aging, 2020; 87: 78-88. PMCID: PMC7064393.
  • Pettigrew C, Soldan A, Zhu Y, Qing C, Wang M-C, Moghekar A, Miller M, Singh B, Martinez O, Fletcher E, DeCarli C, Albert M. Cognitive reserve and rate of change in Alzheimer’s and cerebrovascular disease biomarkers among cognitively normal individuals. Neurobiology of Aging, 2020; 88: 33-41. PMCID: PMC7160864.
  • Pettigrew C, Soldan A, Wang J, Wang M-C, Arthur K, Moghekar A, Gottesman R, Albert M. Association of midlife vascular risk and AD biomarkers with subsequent cognitive decline. Neurology, 2020a, 95: e3093-e3103. PMCID: PMC7734925.
  • Soldan A, Pettigrew C, Xu, Y, Wang M-C, Moghekar A, Gottesman R, Singh B, Martinez O, Fletcher E, DeCarli C, Albert M. White matter hyperintensities and CSF AD biomarkers in preclinical Alzheimer’s disease. Neurology, 2020; 94: e950-e960. PMCID PMC7238945
  • Chan C, Soldan A, Pettigrew C, Wang J, Albert M, Rosenberg P. Depressive symptoms and CSF Alzheimer’s disease biomarkers in relation of clinical symptom onset of mild cognitive impairment. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 2020; 24: 312016. PMCID: PMC7513625
  • Luo J, Agboola F, Grant E, Masters C, Albert M, Johnson S, McDade E, Fagan A, Benzinger T, Hassenstab J, Bateman J, Morris J, Perrin R, Chatwal J, Jucker M, Ghetti B, Cruchaga C, Graff-Radford N, Schofeld P, Mori H, Xiong C. Sequence of Alzheimer biomarker changes in cognitively normal adults: A cross-sectional study. Neurology, 2020; 95:e3104-3116. PMCID: PMC7734923
  • Kulason S, Tward D, Brown T, Sicat C, Liu C, Bakker A, Gallagher M, Albert M, Miller M.
    Entorhinal and transentorhinal atrophy in preclinical Alzheimer’s disease. Frontiers of Neuroscience, 2020; 14: 804. PMCID: PMC7472871.
  • Bashyam V, Erus G, Doshi J, Habes M, Nasrallah I, Truelove-Hill M, Srinivasan D, Mamourian L, Pomponion R Fan Y, Launer L, Masters C, Maruff P, Zhou C, Volzke H, Johnson S, Fripp J, Koutsouleris N, Sattherthwaite T, Wolf D, Gur R, Gur R, Morris J, Albert M, Grabe H, Resnick S, Bryan N, Wolk D, Shou H, Davatzikos C. MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14 468 individuals worldwide Brain. 2020;143: 2312-2324 PMCID: PMC7364766
  • Koychev I, Vaci N, Bilgel M, An Y, Muniz G, Wong D, Gallacher J, Moghekar A, Albert M, Resnick S. Prediction of rapid amyloid and phosphorylated-tau accumulation in cognitively healthy individuals Alzheimer’s & Dementia, Diagnosis, Assessment and Disease Monitoring, 2020, 14: 804. PMCID: PMC7086102.
  • Ning J, Cai C, Chen Y, Huang X, Wang MC. Semiparametric modelling and estimation of covariate-adjusted dependence between bivariate recurrent events. Biometrics. 2020; 76: 1229-1239. PMCID: PMC7384929
  • Pomponio R, Erus G, Habes M, Doshi J, Srinivasan D, Mamourian E, Bashyam V, Nasrallah I, Satterthwaite T, Fan Y, Launer L, Masters C, Maruff P, Zhou C, Volzke H, Johnson S, Fripp J, Koutsouleris N, Wolff D, Gur R, Gur R, Morris J, Albert M, Grabe H, Resnick S, Bryan N, Wolk D, Shinohara R, Shou H, Davatzikos C. Harmonization of large MRI datasets for the analysis of brain imaging patterns throughout the lifespan. Neuroimage, 2020, 208:116450. PMCID: PMC6980790.
  • Raghavan NS, Dumitrescu L, Mormino E, Mahoney E, Lee AJ, Gao Y, Bilgel M, Goldstein D, Harrison T, Engelman CD, Saykin AJ, Whelan CD, Liu JZ, Jagust W, Albert M, Johnson SC, Yang H, Johnson K, Aisen P, Resnick SM, Sperling R, De Jager PL, The Alzheimer’s Disease Neuroimaging Initiative, Schneider J, Bennett DA, Schrag M, Vardarajan B, Hohman TJ, Mayeux R. Association between common variants in RBFOX1, an RNA binding protein, and brain amyloidosis in early and preclinical Alzheimer’s disease. JAMA Neurology, 2020, 77: 1-11. PMCID: PMC7309575.
  • Sathe G, Manganaparthi K, Jain A, Darrow J, Troncoso J, Albert M, Moghekar A, Pandey A. Multiplexed phosphoproteomic study of brain in patients with Alzheimer’s disease and age-matched cognitively healthy controls. OMICS: A Journal of Integrative Biology, 2020; 24:216-227. PMCID: PMC7366319.
  • Soldan A, Pettigrew C, Albert M. Cognitive reserve from the perspective of preclinical Alzheimer’s disease: 2020 Update. Clin Geriatr Med, 2020; 36: 247-263. PMCID: PMC7838205
  • Soldan A, Pettigrew C, Zhu Y, Wang M-C, Gottesman R, DeCarli C, Albert M, Cognitive reserve and midlife vascular risk: cognitive and clinical outcomes. Annals of Clinical and Translational Neurology, 2020; 7: 1307-1317. PMCID: PMC7448143
  • Sun Y, Chiou S, Wang MC. ROC-guided survival trees and ensembles. Biometrics. 2020, 76: 1177-1189. PMCID: PMC8491647
  • Tward D, Brown T, Kageyama Y, Patel J, Hou Z, Mori S, Albert M, Troncoso J, Miller M. Diffeomorphic registration with intensity transformation and missing data: Application to 3D digital pathology of Alzheimer’s disease. Frontiers in Neuroscience, 2020; 14:1-18. PMCID: PMC7027169
  • Wang Z, Tang Z, Zhu Y, Pettigrew C, Soldan A, Gross A, Albert M. AD risk score for the early phases of disease based on unsupervised machine learning. Alzheimers & Dementia, 2020; 16: 1524-1533. PMCID: PMC7666001.
  • Walker KA, Gross AL, Moghekar AR, Soldan A, Pettigrew C, Hou X, Lu H, Alfini AJ, Bilgel M, Miller MI, Albert MS, Walston J. Association of peripheral inflammatory markers with connectivity in large-scale functional brain networks of non-demented older adults. Brain, Behavior, and Immunity, 2020, 87: 388-396. PMCID: PMC7316598.

2019

  • Wu D, Albert M, Soldan A, Pettigrew C, Oishi K, Tomogane Y, Ye C, Ma T, Miller M, Mori S. Multi-atlas based detection and localization (MADL) for location-dependent quantification of white matter hyperintensities. Neuroimage Clinical, 2019; 22:101772. PMCID: PMC6444296.
  • Younes L, Albert M, Moghekar A, Soldan A, Pettigrew C, Miller M. Identifying changepoints in biomarkers during the preclinical phase of Alzheimer’s disease. Frontiers of Aging Neuroscience, 2019; 11:74. PMCID: PMC6454004
  • Lin Z, Sur S, Soldan A, Pettigrew C, Miller M, Oishi K, Moghekar A, Pillai J, Albert M, Lu H. Brain oxygen extraction using MRI in older individuals: relationship to apolipoprotein E genotype and amyloid burden. Radiology, 2019; 292:140-148. PMCID: PMC6604795.
  • Soldan A, Moghekar A, Walker K, Pettigrew C, Hou Z, Lu H, Miller M, Alfini A, Albert M, Xu D, Xiao M-F, Worley P. Resting-state functional connectivity is associated with cerebrospinal fluid levels of the synaptic protein NPTX2 in non-demented older adults. Frontiers of Aging Neuroscience, 2019; 11:132. PMCID: PMC6568192.
  • Gross AL, Walker K, Moghekar A, Pettigrew C, Soldan A, Albert M, Walston J. Plasma markers of inflammation linked to clinical progression and decline during preclinical AD. Frontiers of Aging Neuroscience, 2019; 11: 229. PMCID: PMC6742958.
  • Liu C-F, Padhy S, Ramachandran S, Wang V, Efimov A, Bernal A, Shi L, Vaillant M, Ratnanather T, Caffo B, Albert M, Miller M. Using deep Siamese neural networks for detection of brain asymmetries associated with Alzheimer’s disease and mild cognitive impairment. Magnetic Resonance Imaging, 2019; 64: 190-199. PMCID: PMC6874905
  • Xiong C, Luo J, Agboola F, Li Y, Albert M, Johnson S, Koscik R, Masters C, Soldan A, Villemagne V, Li Q-X, McDade E, Fagan A, Masoumzadeh P, Benzinger T, Hassenstab J, Bateman R, Morris J. A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer’s disease from young adulthood and designing prevention trials. Alzheimers & Dementia, 2019; 15: 1448-1457. PMCID: PMC6874758
  • Ye C, Albert M, Brown T, Bilgel M, Hsu J, Ma T, Caffo B, Miller M, Mori S, Oishi K. Extended multimodal whole-brain anatomical covariance analysis: detection of disrupted covariance networks related to amyloid deposition. Heliyon, 2019; e02074. PMCID: PMC6656959
  • Chan C, Soldan A, Pettigrew C, Wang M.C, Wang J, Albert M, Rosenberg P. Depressive symptoms in relation to clinical symptom onset of mild cognitive impairment. International Psychogeriatrics, 2019; 31: 561-569. PMCID: PMC6458104
  • Soldan A, Pettigrew C, Fagan A, Schindler S, Moghekar A, Fowler C, Li Q-X, Collins S, Carlsson C, Asthana S, Masters C, Johnson S, Morris J, Albert M, Gross A. ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes. Neurology, 2019; 92: e1567-e1579. PMCID: PMC6448449
  • Kulason S, Tward DJ, Brown T, Sicat CS, Liu CF, Ratnanather JT, Younes L, Bakker A, Gallagher M, Albert M, Miller MI. Cortical thickness atrophy in the transentorhinal cortex in mild cognitive impairment. Neuroimage Clinical. 2019; 21:101617. PMCID: PMC6412863.
  • Sathe G, Na C, Santosh R, Magunundu A, Albert M, Moghekar A, Pandey A. Quantitative proteomic profiling of cerebrospinal fluid to identify candidate biomarkers for Alzheimer’s disease. Proteomics Clinical Applications, 2019; 4: e1800105. PMCID: PMC6639119
  • Dumitrescu L, Barnes LL, Thambisetty M, Beecham G, Kunkle B, Bush WS, Gifford KA, Chibnik LB, Mukherjee S, De Jager PL, Kukull W, Crane PK, Resnick SM, Keene CD, Montine TJ, Schellenberg GD, Deming Y, Chao MJ, Huentelman M, Martin ER, Hamilton-Nelson K, Shaw LM, Trojanowski JQ, Peskind ER, Cruchaga C, Pericak-Vance MA, Goate AM, Cox NJ, Haines JL, Zetterberg H, Blennow K, Larson EB, Johnson SC, Albert M, Bennett DA, Schneider JA, Jefferson AL, Hohman TJ. Sex differences in the genetic predictors of Alzheimer’s pathology. Brain. 2019; 142:2581-2589. PMCID: PMC6736148
  • Pettigrew C, Soldan A. Defining cognitive reserve and implications for cognitive aging. Curr Neurol Neurosci Rep, 2019; 19: 1. PMCID: PMC30627880.
  • Pettigrew C, Shao Y, Zhu Y, Grega M, Brichko R, Wang M-C, Carlson M, Albert M, Soldan A. Self-reported lifestyle activities in relation to longitudinal cognitive trajectories. Alzheimer’s Disease & Associated Disorders, 2019; 33: 21-28. PMCID: PMC6389389

2018

  • Albert M, Zhu Y, Moghekar A, Mori S, Miller M, Soldan A, Pettigrew C, Selnes O, Li S, Wang M-C. Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years. Brain, 2018, 141: 877-887. PMCID: PMC5837651.
  • Sathe G, Na C, Renuse S, Madugundu A, Albert M, Moghekar A, Pandey A. Phosphotyrosine profiling of human cerebrospinal fluid. Clinical Proteomics, 2018, 15: 29. PMCID: PMC6136184.
  • Deming Y, Dumitrescu L, Barnes L, Thambisetty M, Kunkle B, Gifford K, Bush W, Chibnik L, Mukherjee S, DeJager P, Kukull W, Huentelman M, Crane P, Resnick S, Keen C, Montine T, Schellenberg G, Haines J, Zetterberg H, Blennow K, Larson E, Johnson S, Albert M, Moghekar A, DelAquila J, Fernandez M, Budde J, Hassenstab J, Fagan A, Riemenschneider M, Petersen R, Minthon L, Chao M, VanDeerlin V, Lee V, Shaw L, Trojanowski J, Peskind E, Li G, Davis L, Sealock J, Cox N, ADNI, ADGC, Goate A, Schneider J, Jefferson A, Cruchaga C, Hohman T. Sex-specific genetic predictors of Alzheimer’s disease biomarkers. Acta Neuropathologica, 2018; 136:857-872. PMCID: PMC6280657.
  • Hohman T, Dumitrescu L, Barnes L, Thambisetty M, Beecham G, Kunkle B, Gifford K, Bush W, Chibnik L, Mukherjee S, De Jager P, Kukull W, Crane P, Resnick S, Keene C, Montine T, Schellenberg G, Haines J, Zetterberg H, Blennow K, Larson E, Johnson S, Albert M, Bennett D, Schneider J, Jefferson A. Sex-specific associations of apolipoprotein E with cerebrospinal fluid levels of tau. JAMA Neurology, 2018; 75: 989-998. PMCID: PMC6142927.
  • Soldan A, Pettigrew C, Albert M. Evaluating cognitive reserve through the prism of preclinical Alzheimer’s disease. Psychiatric Clinics of North America, 2018; 41: 65-77. PMCID: PMC5806143

2017

  • Pettigrew C, Soldan A, Zhu Y, Wang M-C, Brown T, Miller M, Albert M. Cognitive reserve and cortical thickness in preclinical Alzheimer’s disease. Brain Imaging and Behavior, 2017; 11:357-367. PMCID: PMC5577409.
  • Varma V, Varma S, An Y, Hohman T, Casanova R, Beri A, Dammer E, Seyfried N, Pletnikova O, Moghekar A, Wilson M, Lah J, O’Brien R, Levey A, Troncoso J, Albert M, Thambisetty M. Alpha-2 macroglobulin in Alzheimer’s disease: a marker of neuronal injury through the RCAN1 pathway. Molecular Psychiatry, 2017; 22: 13-23. PMCID: PMC5726508.
  • Gross AL, Hassenstab J, Johnson S, Clark LR, Resnick SM, Kitner-Triolo M, Masters C, Maruff P, Morris JC, Soldan A, Pettigrew C, Albert M. A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The Preclinical AD Consortium. Alzheimer’s and Dementia: Diagnosis, Assessment & Disease Monitoring, 2017, 8: 147-155. PMCID: PMC5476965.
  • Sacktor N, Soldan A, Grega M, Farrington L, Cai Q, Wang, M-C, Gottesman R, Turner RS, Albert M. The BIOCARD Index: A summary measure to predict onset of mild cognitive impairment. Alzheimer Disease & Associated Disorders, 2017; 31:114-119. PMCID: PMC5443710
  • Pettigrew C, Soldan A, Sloane K, Cai Q, Wang J, Wang M-C, Moghekar A, Miller M, Albert M. Progressive medial temporal lobe atrophy during preclinical Alzheimer’s disease. NeuroImage Clinical, 2017, 16:439-446. PMCID: PMC5577409.
  • Soldan A, Pettigrew C, Cai Q, Wang J, Wang MC, Moghekar A, Miller M, Albert M. Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer’s disease. Neurobiology of Aging, 2017: 60: 164-172. PMCID: PMC5679465.
  • Tward D, Sicat C, Brown T, Bakker A, Gallagher M, Albert M, Miller M. Entorhinal and transentorhinal atrophy in mild cognitive impairment using longitudinal morphometry. Alzheimers & Dementia, 2017; 9: 41-50. PMCID: PMC5608074.
  • Tward D, Brown T, Kageyama Y, Patel J, Hou Z, Mori S, Albert M, Troncoso J, Miller M. Diffeomorphic registration with intensity transformation and missing data: Application to 3D digital pathology of Alzheimer’s disease. Frontiers in Neuroscience, 2020; 14:1-18. PMCID: PMC7027169
  • Cai Q, Wang M-C, Chan KC. Joint modeling of longitudinal, recurrent events and failure time data for survivor’s population. Biometrics, 2017; 73: 1150-1160. PMCID: PMC5791160.
  • Mori S, Kageyama Y, Hou Z, Aggarwal M, Patel J, Brown T, Miller M, Wu D, Troncoso J. Elucidation of white matter tracts of the human amygdala by detailed comparison between high-resolution postmortem magnetic resonance imaging and histology. Frontiers of Neuroanatomy, 2017; 11: 16. PMCID: PMC5348491.

2016

  • Wennberg A, Spira A, Pettigrew C, Soldan A, Zipunnikov V, Rebok G, Roses A, Lutz M, Miller M, Thambisetty M, Albert M. Blood glucose levels and cortical thinning in cognitively normal, middle-aged adults. Neurological Sciences, 2016; 365: 89-95. PMCID: PMC4876973
  • Soldan A, Pettigrew C, Cai Q, Wang M-C, Moghekar A, O’Brien R, Albert M. Hypothetical preclinical AD groups and longitudinal cognitive change. JAMA Neurol 2016; 73:698-705. PMCID: PMC5173327.
  • Soldan, A, Pettigrew C, Moghekar A, Albert M. Computerized cognitive tests are associated with biomarkers of Alzheimer’s disease in cognitively normal individuals 10 years prior. J Intl Neuropsychol Soc, 2016; 22:968-977. PMCID: PMC5154173
  • Gross AL, Mungas D, Leoutsakos J, Albert M, Jones RN. Alzheimer’s disease severity, objectively determined and measured. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 2016; 4: 159-168. PMCID: PMC5078784
  • Leoutsakos J-M, Gross AL, Jones RN, Albert M, Breitner JC. Alzheimer’s progression score: development of a biomarker summary outcome for AD prevention trials. Journal of Prevention of Alzheimer’s Disease, 2016; 3: 229-235. PMCID: PMC5639716.
  • Arguillere S, Miller M, Younes L. Diffeomorphic surface registration with atrophy constraints. SIAM J Imaging Sci, 2016; 9: 975-1003. PMCID: PMC9148198.
  • Pettigrew C, Soldan A, Zhu Y, Wang M-C, Moghekar A, Brown T, Miller M, Albert M. Cortical thickness in relation to clinical symptom onset in preclinical AD. Neuroimage Clinical, 2016; 12: 116-122. PMCID: PMC4932610.

2015

  • Soldan A, Pettigrew C, Lu Y, Wang M-C, Selnes O, Albert, A, Brown T, Ratnanather T, Younes L, Miller M. Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical AD, Human Brain Mapping, 2015, 36: 2826-2841. PMCID: PMC4478167.
  • Miller MI, Ratnanather J, Tward D, Brown T, Lee D, Ketcha M, Mori K, Wang M-C, Mori S, Albert M, Younes L. Network degeneration in Alzheimer’s disease via MRI based shape diffeomorphometry and high-field atlasing. Frontiers in Bioengineering and Biotechnology, 2015, 3:54. PMCID: PMC4515983.
  • Miller MI, Younes L, Ratnanather T, Brown T, Trinh H, Lee DS, Tward D, Mahon PB, Mori S, Albert M. Amygdalar atrophy in symptomatic Alzheimer’s disease based on diffeomorphometry: the BIOCARD cohort. Neurobiology of Aging, 2015; 36 (Suppl 1): S3-S10. PMCID: PMC4271320.
  • Pettigrew C, Soldan A, Moghekar A, Wang M-C, Gross A, O’Brien R, Albert M. Relationship between cerebrospinal fluid biomarkers of Alzheimer’s disease and cognition in cognitively normal older adults. Neuropsychologia, 2015, 78:63-72. PMCID: PMC4630154.
  • Toledo J, Zetterberg H, van Harten AC, Glodzik L, Martinez-Lage P, Bocchio-Chaivetto L, Rami L, Hansson O, Sperling R, Engelboroghs S, Osorio R, Vanderstichele H, Vandijck M, Hampel H, Teipl S, Moghekar A, Albert M, Hu W, Monge Argiles J, Gorostidi A, Teunissen C, De Deyn PP, Hyman B, Molineuvo J, Frisoni G, Linazasoro G, de Leon M, van der Flier W, Scheltens P, Blennow K, Shaw L, Trojanowski J. Alzheimer’s disease cerebrospinal fluid biomarker in cognitively normal subjects. Brain 2015; 138: 2701-2715. PMCID: PMC4643624
  • Resnick S, Bilgel M, Moghekar A, An Y, Cai Q, Wang M-C, Thambisetty M, Prince J, Zhou Y, Soldan A, Wong D, O’Brien R, Ferrucci L, Albert M. Changes in Abeta biomarkers and associations with ApoE genotype in two longitudinal cohorts. Neurobiol Aging 2015,36: 2333-2339. PMCID: PMC5084914
  • Tang X, Crochetti D, Kutten K, Ceritoglu C, Albert M, Mori S, Mostofsky S, Miller M. Segmentation of brain magnetic resonance images based on multi-atlas likelihood fusion: testing using data with a broad range of anatomical and photometric profiles. Frontiers in Neuroscience, 2015, 9: 61. PMCID: PMC4347448

2014

  • Younes L, Albert M, Miller M. Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer’s disease. NeuroImage, 2014, 5: 178-187. PMCID: PMC4110355.
  • Albert M, Soldan A, Gottesman R, McKhann G, Sacktor N, Farrington L, Grega M, Turner R, Lu Y, Li S, Wang MC, Selnes O. Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype. Current Alzheimers Research, 2014, 11: 773-784. PMCID: PMC4163954.
  • Miller M, Younes L, Ratnanather J, Brown T, Trinh H, Lee D, Tward D, Mahon P, Mori S, Albert M. Amydalar atrophy in symptomatic AD based on diffeomorphometry: the BIOCARD cohort. Neurobiol Aging, 2014; 36: S3-S10. PMCID: PMC4271320.
  • Semba R, Moghekar A, Hu J, Sun K, Turner R, Ferrucci L, O’Brien R. Klotho in the cerebrospinal fluid of adults with and without Alzheimer’s disease. Neurosci Lett, 2014; 558: 37-40. PMCID: PMC4037850

2013

  • Moghekar A, Li S, Lu Y, Li M, Wang MC, Albert M, O’Brien R. CSF biomarker changes precede symptom onset of mild cognitive impairment. Neurology. 2013; 81: 1753-1758. PMCID: PMC3821715.
  • Soldan A, Pettigrew C, Li S, Wang MC, Moghekar A, Selnes OA, Albert M, O’Brien R. Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer’s disease. Neurobiol Aging. 2013; 34: 2827-2834. PMCID: PMC3823238.
  • Pettigrew C, Soldan A, Li S, Lu Y, Wang MC, Selnes OA, Moghekar A, O’Brien R, Albert M. Relationship of cognitive reserve and APOE status to the emergence of clinical symptoms in preclinical Alzheimer’s disease. Cogn Neurosci. 2013; 4: 136-142. PMCID: PMC3836845.
  • Miller MI, Younes L, Ratnanather JT, Brown T, Trinh H, Postell E, Lee DS, Wang M-C, Mori S, O’Brien R, Albert M. The diffeomorphometry of temporal lobe structures in preclinical Alzheimer’s disease. NeuroImage – Clinical, 2013; 3: 352-360. PMCID: PMC3863771.
  • Li S, Okonkwo O, Albert M, Wang MC. Variation in variables that predict progression from MCI to AD dementia over the duration of follow-up. Amer J Alzheimers Dis, 2013; 1: 12-28. PMCID: PMC3919474.
  • Liu X, Jin Z, O’Brien R, Bathon J, Dietz HC, Grote E, Van Eyk JE. Constrained selected reaction monitoring: quantification of selected post-translational modifications and protein isoforms. Methods, 2013; 61: 304-312. PMCID: PMC3990191.
  • Wang M-C, Li S. ROC analysis for multiple markers with tree-based classification. Journal of Lifetime Data Analysis 2013; 19:79-99. PMCID: PMC3633731.

2012

  • Moghekar A, Goh J, Li M, Tang X, Albert M, O’Brien R. Cerebrospinal fluid Aß peptide and tau levels show little fluctuation in older subjects. Arch Neurol, 2012; 69: 246-250. PMCID: PMC3310240.
  • Miller MI, Younes L, Ratnanather JT, Brown T, Reigel T, Trinh H, Tang Z, Barker P, Mori S. Albert M. Amygdala atrophy in MCI/Alzheimer’s disease in the BIOCARD cohort based on diffeomorphic morphometry. Med Image Comput Assist Interv, 2012; 155-166. PMCID: PMC4063307.
  • Wang M-C, Li S. Bivariate marker measurements and ROC analysis. Biometrics, 2012; 68: 1207–1218. PMCID: PMC3530667.

2011

  • Okonkwo OC, Mielke MM, Griffith HR, Moghekar AR, O’Brien RJ, Shaw LM, Trojanowski JQ, Albert MS, the Alzheimer’s Disease Neuroimaging Initiative. Cerebrospinal fluid profiles predict prospective course and outcome among persons with amnestic mild cognitive impairment. Arch Neurol 2011, 68: 113-119. PMCID: PMC3058271.
  • Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, Bocchio-Chiavetto L, Blankenstein MA, Carrillo MC, Chalbot S, Coart E, Chiasserini D, Cutler N, Dahlfors G, Duller S, Fagan AM, Forlenza O, Frisoni GB, Galasko D, Galimberti D, Hampel H, Handberg A, Heneka MT, Herskovits AZ, Herukka SK, Holtzman DM, Humpel C, Hyman BT, Iqbal K, Jucker M, Kaeser SA, Kaiser E, Kapaki E, Kidd D, Klivenyi P, Knudsen CS, Kummer MP, Lui J, Llado A, Lewczuk P, Li QX, Martins R, Masters C, McAuliffe J, Mercken M, Moghekar A, Molinuevo JL, Montine TJ, Nowatzke W, O’Brien R, Otto M, Paraskevas GP, Parnetti L, Petersen RC, Prvulovic D, de Reus HP, Rissman RA, Scarpini E, Stefani A, Soininen H, Schroder J, Shaw LM, Skinningsrud A, Skrogstad B, Spreer A, Talib L, Teunissen C, Trojanowski JQ, Tumani H, Umek RM, Van Broeck B, Vanderstichele H, Vecsei L, Verbeek MM, Windisch M, Zhang J, Zetterberg H, Blennow K. The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers. Alzheimers & Dementia. 2011; 7: 386-395. PMCID: PMC3710290.